PASSANTINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 418
EU - Europa 268
AS - Asia 82
SA - Sud America 2
Totale 770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 418
IE - Irlanda 73
PL - Polonia 59
IT - Italia 56
SE - Svezia 56
HK - Hong Kong 44
CN - Cina 13
JO - Giordania 13
RU - Federazione Russa 11
CH - Svizzera 7
VN - Vietnam 5
SG - Singapore 4
IN - India 3
GB - Regno Unito 2
PY - Paraguay 2
DE - Germania 1
FR - Francia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 770
Salva come PNG Salva come JPEG
Città #
Dublin 73
Warsaw 56
Fairfield 55
Ashburn 42
Chandler 39
Hong Kong 32
Seattle 28
Wilmington 24
Lawrence 19
Altamura 18
New York 18
Woodbridge 18
Cambridge 17
Houston 17
Florence 16
Buffalo 12
Princeton 12
Boston 10
Beijing 9
Moscow 9
Ann Arbor 8
Bern 7
Dong Ket 4
Hillsboro 4
Kent 4
San Diego 4
Shanghai 4
Singapore 4
Andover 3
Medford 3
Naples 3
Boardman 2
Falls Church 2
Prato 2
Pune 2
Roncade 2
Salerno 2
Siena 2
Washington 2
West Jordan 2
Bruino 1
Cetraro 1
Chennai 1
Clifton 1
Duncan 1
Frankfurt am Main 1
Genova 1
Hanoi 1
Kilburn 1
London 1
Mem Martins 1
Milan 1
Monte San Savino 1
Norwalk 1
Padova 1
Totale 605
Salva come PNG Salva come JPEG
Nome #
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 108
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 107
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 68
Impact of cardiovascular involvement on the clinical course of paediatric mitochondrial disorders 66
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 53
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 50
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 45
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 38
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 37
Hidden familial cardiomyopathies in children: Role of genetic testing 36
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 31
Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study 30
Clinical pathway for cardiomyopathies: A genetic testing strategy proposed by ANMCO in Tuscany 24
Indicazioni all’esecuzione del test genetico nella diagnosi delle cardiomiopatie ad esordio pediatrico: percorso clinico della Società Italiana di Cardiologia Pediatrica 24
Clinical Exome Sequencing Revealed a De Novo FLNC Mutation in a Child with Restrictive Cardiomyopathy 22
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy 22
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 18
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 13
Totale 792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.331
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/2020117 1 0 0 5 9 13 22 20 18 9 12 8
2020/2021120 9 13 10 15 5 6 4 11 10 26 5 6
2021/202271 0 4 4 2 2 2 2 5 11 2 16 21
2022/2023297 21 64 17 1 20 54 39 21 37 4 10 9
2023/2024168 2 16 22 3 7 41 9 47 2 15 4 0
Totale 792